Skip to content

Homoeopathic Treatment Of Urticaria

An Interventional Study To Assess The Effectiveness Of Individualized Homoeopathic Medicines Using Fifty Millesimal Potency In The Management Of Chronic Urticaria - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098335
Enrollment
50
Registered
2025-12-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: L509- Urticaria, unspecified

Interventions

Intervention1: Individualized Homoeopathic Medicine: Fifty Millesimal potency will be used and all medicines procured will be GMP certified and will be dispensed from the dispensary of MBHMCANDH.Each

Sponsors

Dr Sonali Priya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients presenting with clinical features of chronic spontaneous urticaria, such as wheals, nettle rash, and itching, with a duration of more than 6 weeks. 2. Patients aged 18 to 60 years. 3. Patients who are willing to participate voluntarily and provide written informed consent. 4. Patients who have not received any homoeopathic treatment for the past two weeks prior to enrolment.

Exclusion criteria

Exclusion criteria: 1. Patients who are unwilling to participate or refuse to provide written informed consent. 2. Patients diagnosed with any underlying malignancy or other medical conditions requiring emergency medical intervention. 3. Patients currently undergoing homoeopathic treatment for any chronic disease within the past six months. 4. Pregnant females and lactating mothers.

Design outcomes

Primary

MeasureTime frame
Reduction of clinical severity of urticaria is Measured using Urticaria Control Test UCT-7). Score is assessed at baseline and at regular 4 weeks using Homoeopathic individualised medicine in fifty millesimal potency.Timepoint: Outcome will be assessed at baseline,after 4,8 and 12 weeks

Secondary

MeasureTime frame
Improvement in quality of life measured using CU-Q2oL (Chronic Urticaria Quality of Life Questionnaire). Recorded at baseline and post-treatment.Timepoint: 3 months

Countries

India

Contacts

Public ContactProf Dr MIhir Kanti Biswas

Mahesh Bhattacharyya Homoeopathic Medical College And Hospital

drmkb33@gmail.com9051236301

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026